Charles Schwab’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
120,285
+6,635
| +6% | +$65.9K | ﹤0.01% | 2841 |
|
|
2025
Q1 | $1.08M | Buy |
113,650
+2,314
| +2% | +$22K | ﹤0.01% | 2813 |
|
|
2024
Q4 | $1.54M | Buy |
111,336
+37,868
| +52% | +$523K | ﹤0.01% | 2755 |
|
|
2024
Q3 | $1.12M | Hold |
73,468
| – | – | ﹤0.01% | 2885 |
|
|
2024
Q2 | $350K | Buy |
73,468
+59,989
| +445% | +$286K | ﹤0.01% | 3326 |
|
|
2024
Q1 | $91.5K | Hold |
13,479
| – | – | ﹤0.01% | 3312 |
|
|
2023
Q4 | $65.9K | Hold |
13,479
| – | – | ﹤0.01% | 3379 |
|
|
2023
Q3 | $46.1K | Hold |
13,479
| – | – | ﹤0.01% | 3412 |
|
|
2023
Q2 | $64.4K | Hold |
13,479
| – | – | ﹤0.01% | 3384 |
|
|
2023
Q1 | $56.9K | Buy |
+13,479
| New | +$56.9K | ﹤0.01% | 3328 |
|
|
2022
Q3 | – | Sell |
-14,832
| Closed | -$52K | – | 3513 |
|
|
2022
Q2 | $52K | Hold |
14,832
| – | – | ﹤0.01% | 3385 |
|
|
2022
Q1 | $51K | Buy |
+14,832
| New | +$51K | ﹤0.01% | 3525 |
|
|
2021
Q1 | – | Sell |
-14,545
| Closed | -$50K | – | 3492 |
|
|
2020
Q4 | $50K | Hold |
14,545
| – | – | ﹤0.01% | 3350 |
|
|
2020
Q3 | $77K | Buy |
+14,545
| New | +$77K | ﹤0.01% | 3256 |
|